Journal of Clinical Densitometry
Volume 11, Issue 4 , Pages 525-531 , October 2008

Use of Lowest Single Lumbar Spine Vertebra Bone Mineral Density T-Score and Other T-Score Approaches for Diagnosing Osteoporosis and Relationships with Vertebral Fracture Status

  • Peiqi Chen

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
  • ,
  • Paul D. Miller

      Affiliations

    • Colorado Center for Bone Research, Lakewood, CO, USA
  • ,
  • Neil C. Binkley

      Affiliations

    • University of Wisconsin, Osteoporosis Research Program, Madison, WI, USA
  • ,
  • David L. Kendler

      Affiliations

    • Osteoporosis Research Centre, Vancouver, BC, Canada
  • ,
  • Mayme Wong

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
    • Corresponding Author InformationAddress correspondence to: Mayme Wong, MD, Lilly Technology Center, 1400 West Raymond Street, DC 4108, Indianapolis, IN 46221, USA.
  • ,
  • Kelly Krohn

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA

Received 4 January 2008 ,Revised 21 April 2008 ,Accepted 30 April 2008.

References 

  1. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2005;353:595–603
  2. Ettinger B, Black DM, Nevitt MC, et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1992;7:449–456
  3. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128:793–800
  4. Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215–1220
  5. Lewiecki EM, Watts NB, McClung MR, et al. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004;89:3651–3655
  6. World Health Organization. 2007 WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. Summary Meeting Report, Brussels, Belgium, 5–7 May 2004. Available at: htttp://www.who.int/chp/topics/osteoporosis.pdf. Accessed: Feb 28, 2008.
  7. Hans D, Downs RW, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9:15–21
  8. O'Gradaigh D, Debiram I, Love S, et al. A prospective study of discordance in diagnosis of osteoporosis using spine and proximal femur bone densitometry. Osteoporos Int. 2003;14:13–18
  9. Masud T, Langley S, Wiltshire P, et al. Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ. 1993;307:172–173
  10. Rand T, Seidl G, Kainberger F, et al. Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy X-ray absorptiometry (DXA). Calcif Tissue Int. 1997;60:430–433
  11. Hansen KE, Vallarta-Ast N, Krueger D, et al. Use of the lowest vertebral body T-score to diagnose lumbar osteoporosis in men: is “cherry picking” appropriate?. J Clin Densitom. 2004;7:376–381
  12. Sahota O, Pearson D, Cawte SW, et al. Site-specific variation in the classification of osteoporosis, and the diagnostic reclassification using the lowest individual lumbar vertebra T-score compared with the L1-L4 mean, in early postmenopausal women. Osteoporos Int. 2000;11:852–857
  13. Binkley N, Bilezikian JP, Kendler DL, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006;9:4–14
  14. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J. 1996;312:1254–1259
  15. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA. 1999;282:637–645
  16. Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial. Bone. 2003;33:293–300
  17. Fowler C, Hanson J, Bisek J, Mazess R. Reanalysis of DPX data with DPX-IQ software. Osteoporos Int. 1997;7:284-284
  18. Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int. 2001;12:438–444
  19. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–489
  20. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137–1148
  21. Vokes TJ, Gillen DL, Lovett J, Favus MJ. Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures. J Clin Densitom. 2005;8:206–215
  22. Arabi A, Baddoura R, Awada H, et al. Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures. Bone. 2007;40:1060–1065
  23. Schneider J, Bundschuh B, Spath C, et al. Discrimination of patients with and without vertebral fractures as measured by ultrasound and DXA osteodensitometry. Calcif Tissue Int. 2004;74:246–254
  24. Cauley JA, Zmuda JM, Wisniewski SR, et al. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2004;15:32–37
  25. Fujiwara S, Kasagi F, Masunari N, et al. Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res. 2003;18:1547–1553
  26. Siris ES, Genant HK, Laster AJ, et al. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18:761–770

PII: S1094-6950(08)00070-X

doi: 10.1016/j.jocd.2008.04.009

Journal of Clinical Densitometry
Volume 11, Issue 4 , Pages 525-531 , October 2008